Monday, March 25, 2013

Drug News Digest - Mar 25

The Supreme Court is to decide whether the maker of a brand-name drug can pay a generic-drug company to keep its version off the market.
March 24, 2013 -- NYT > U.S.
U.S. health regulators on Friday approved the first ever antibody that can counteract the effect of all types of toxins known to cause botulism, a ...
March 23, 2013 -- Reuters
The head of the U.S. Food and Drug Administration proposed on Friday that the agency charge fees to compounding pharmacies to pay for the oversigh ...
March 22, 2013 -- Reuters
Johnson & Johnson may soon cause frown lines at Allergan Inc, maker of Botox. J&J expects to seek U.S. approval next year for an anti-wrinkle drug ...
March 24, 2013 -- Reuters
Women who suffer from migraines, and migraines with aura in particular, may have an elevated risk of thrombotic complications when they use combin ...
March 24, 2013 -- MedPage Today

No comments:

Post a Comment